Yahoo Web Search

Search results

    • Novavax Reports First Quarter 2024 Financial Results and Operational Highlights

      WJTV Jackson· 3 hours ago

      ...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...

    • Novavax stock soars 40% on Sanofi partnership

      Novavax stock soars 40% on Sanofi partnership

      Investing.com· 4 hours ago

      The company's revenue was $93.85 million, significantly falling short of the consensus estimate of $141.16 million. Despite missing Q1 estimates, NVAX...